Wednesday, October 07, 2020 1:40:55 AM
''In the past year, we completed the transactions that we were working on in 2018 and 2019, including the purchase in May 2020 of the Bakersfield Biorefinery, the strategic partnership with ExxonMobil Corporation to monetize the fuels expected to be produced at the Bakersfield Biorefinery, and the various financing arrangements described in this Annual Report to fund the conversion and operation of the Bakersfield Biorefinery. These completed transactions are necessary to establish this Company’s ability to commercialize renewable fuel from Camelina and other feedstocks at the Bakersfield Biorefinery. However, because we were singularly focused on the acquisition and financing of the Bakersfield Biorefinery and on the establishment of our relationship with U.S. farmers for the cultivation of Camelina as a renewable fuels feedstock, the Company did not engage in any activities that generated revenues in 2018 or 2019.''
And we know who is the largest Cali farmer is; our jatropha partner Mr. Stewart Resnick...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155860751&txt2find=resnick
e
emit...
Recent GCEH News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 07:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 01:34:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:15:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 08:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 08:00:10 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/23/2023 08:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 01:42:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 01:41:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 03:28:36 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/02/2023 07:53:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 02:39:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/27/2023 09:15:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 09:19:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2023 10:23:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM